Status:

TERMINATED

Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases

Lead Sponsor:

Pharmacyclics LLC.

Conditions:

Neoplasm Metastasis

Brain Neoplasms

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The primary purpose of the study is to evaluate if motexafin gadolinium with whole brain radiation therapy followed by a stereotactic radiosurgery boost is a safe and effective treatment.

Detailed Description

Patients will receive three weeks of whole brain radiation therapy concurrent with daily motexafin gadolinium during weeks 2 and 3, followed by a stereotactic radiosurgery boost concurrent with motexa...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years
  • Karnofsky performance status (KPS) ≥ 70
  • Histologically confirmed malignancy with the presence of one to four intraparenchymal brain metastases
  • Each patient must sign a study-specific Informed Consent form

Exclusion

  • Previous cranial radiation
  • Complete resection of all known brain metastases
  • Known leptomeningeal metastases
  • Known liver metastases
  • Clinical or radiologic evidence of progression (other than study lesion\[s) within 1 month prior to enrollment
  • Patients with metastases within 10 mm of the optic apparatus
  • Patients with metastases in the brainstem, midbrain, pons, or medulla
  • Planned chemotherapy during WBRT and/or SRS
  • Uncontrolled hypertension
  • Women who are pregnant or lactating
  • and Laboratory values as follows:
  • LDH \> 1.3 x upper limit of normal (ULN)
  • ANC \< 1500/mm3
  • Platelets \< 50,000/mm3
  • Creatinine \> 2.0 mg/dL
  • AST or ALT \> 3 x ULN
  • Total bilirubin \> 2 x ULN

Key Trial Info

Start Date :

Trial Type :

INTERVENTIONAL

End Date :

Estimated Enrollment :

45 Patients enrolled

Trial Details

Trial ID

NCT00121420

Last Update

May 9 2014

Active Locations (12)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (12 locations)

1

Phoenix, Arizona, United States

2

Aurora, Colorado, United States

3

Cleveland, Ohio, United States

4

Columbus, Ohio, United States